CL2-MMT-SN38

• UNSPSC Description:

  CL2-MMT-SN38 is a SN-38 derivative. SN-38, an anticancer agent, is an active metabolite of the Topoisomerase I inhibitor Irinotecan (CPT-11)[1].

• Target Antigen:

  Topoisomerase

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cl2-mmt-sn38.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1CCC(CC1)CN2C(C=CC2=O)=O)NCC(N=N3)=CN3CCOCCOCCOCCOCCOCCOCCOCCOCCNC(COCC(N[C@@H](CC4=CC=CC=C4)C(N[C@H](C(NC5=CC=C(C=C5)COC(O[C@]6(C7=C(COC6=O)C(N8C(C(C(C8)=C(C9=C%10)CC)=NC9=CC=C%10O)=C7)=O)CC)=O)=O)CCCCNC(C%11=CC=CC=C%11)(C%12=CC=CC=C%12)C%13=CC=C(C=C%13)OC)=O)=O)=O

• Molecular Weight:

  1900.13

• References & Citations:

  [1]Moon SJ, et al. Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapy. J Med Chem. 2008;51(21):6916-6926.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1084888-82-3